Characterization of pre-transcription complexes made at a bacteriophage T4 middle promoter: involvement of the T4 MotA activator and the T4 AsiA protein, a sigma 70 binding protein, in the formation of the open complex

Journal of Molecular Biology
D M HintonM Sharma

Abstract

Bacteriophage T4 middle promoters have excellent matches to the -10 consensus sequence for the sigma 70 subunit of Escherichia coli RNA polymerase, but a binding site for the T4 transcriptional activator MotA replaces the sigma 70 -35 consensus. E. Coli RNA polymerase transcribes from middle promoters with or without the activator. In contrast, transcription by T4-modified E. coli RNA polymerase, which is present during T4 infection, requires NotA. We show that transcription by unmodified polymerase from the T4 middle promoter P uvsx is independent of the specific sequences within the -35 region, and the Dnase I footprint obtained with unmodified polymerase and P uvsx resembles those seen previously with E. coli extended -10" promoters. In contrast, although T4-modified polymerase alond binds P uvsx, promoter unwinding and detection of a Dnase I footprint requires MotA. This footprint is significantly different from that obtained with unmodified polymerase, starting upstream of around position -20. Previous work has indicated that the T4 AsiA protein, which binds tightly to sigma 70, is the phage modification required for MotA activation. We show that in the presence of AsiA, MotA, and otherwise unmodified polymerase, Dnase I p...Continue Reading

Citations

Jun 29, 1999·Cold Spring Harbor Symposia on Quantitative Biology·C A GrossB Young
Mar 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Eric S MillerWolfgang Rüger
Jan 19, 1999·Annual Review of Microbiology·K T Hughes, K Mathee
Oct 30, 2010·Virology Journal·Deborah M Hinton
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·K AdelmanM Buckle
Dec 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sergei NechaevE Peter Geiduschek
Feb 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey L UrbauerEdward N Brody
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·M Jishage, A Ishihama
Jul 17, 2004·The EMBO Journal·Lester J LambertMilton H Werner
Jul 3, 2013·Bacteriophage·Joseph Osmundson, Seth A Darst
Jul 28, 2016·Nucleic Acids Research·Tamara D JamesDeborah M Hinton
Jun 24, 1998·Journal of Molecular Biology·E SeverinovaS A Darst
Mar 21, 2007·Molecular Microbiology·Giedre StoskieneRimas Nivinskas
Apr 8, 2006·The EMBO Journal·Sergei Nechaev, E Peter Geiduschek
Aug 2, 2013·The Journal of Biological Chemistry·Meng-Lun HsiehDeborah M Hinton
Aug 9, 2019·Nucleic Acids Research·Jing ShiYu Feng
May 8, 2004·Molecular Microbiology·Gilbert OrsiniAnnie Kolb
Feb 6, 2017·Transcription·Deborah M Hinton
Aug 10, 1999·Journal of Molecular Biology·S KoleskyE P Geiduschek
Mar 21, 2002·Journal of Molecular Biology·Lidija TruncaiteRimas Nivinskas
May 14, 1999·Current Opinion in Microbiology·J D Helmann
Sep 11, 2002·Journal of Molecular Biology·Scott E KoleskyE Peter Geiduschek
Mar 12, 2003·Journal of Molecular Biology·Lidija TruncaiteRimas Nivinskas
Apr 2, 2005·Protein Expression and Purification·Leonid Minakhin, Konstantin Severinov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.